PeproTech Inc.
Originally published online as doi:10.1189/jlb.0408260 on October 3, 2008

Published online before print October 3, 2008
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jlb.0408260v1
85/1/154    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chernova, I.
Right arrow Articles by Kilpatrick, L. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chernova, I.
Right arrow Articles by Kilpatrick, L. E.
(Journal of Leukocyte Biology. 2009;85:154-164.)
© 2009 by Society for Leukocyte Biology

Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)

Irene Chernova*, Jian-Ping Lai*, Haiying Li*, Lynnae Schwartz{dagger}, Florin Tuluc*, Helen M. Korchak*, Steven D. Douglas* and Laurie E. Kilpatrick*,1

* Division of Allergy and Immunology, Department of Pediatrics, and
{dagger} Department of Anesthesiology and Critical Care Medicine, University of Pennsylvania School of Medicine and the Joseph Stokes Jr. Research Institute, Children’s Hospital of Philadelphia, Philadelphia, Pennsylvania, USA

1 Correspondence: Immunology Section, Room 1208A, Abramson Research Center, Children’s Hospital of Philadelphia, 3615 Civic Center Blvd., Philadelphia, PA 19104, USA. E-mail: kilpatrick{at}email.chop.edu

Substance P (SP) is a potent modulator of monocyte/macrophage function. The SP-preferring receptor neurokinin-1 receptor (NK1R) has two forms: a full-length NK1R (NK1R-F) isoform and a truncated NK1R (NK1R-T) isoform, which lacks the terminal cytoplasmic 96-aa residues. The distribution of these receptor isoforms in human monocytes is not known. We previously identified an interaction among SP, NK1R, and HIV viral strains that use the chemokine receptor CCR5 as a coreceptor, suggesting crosstalk between NK1R and CCR5. The purpose of this study was to determine which form(s) of NK1R are expressed in human peripheral blood monocytes and to determine whether SP affects proinflammatory cellular responses mediated through the CCR5 receptor. Human peripheral blood monocytes were found to express NK1R-T but not NK1R-F. SP interactions with NK1R-T did not mobilize calcium (Ca2+), but SP mobilized Ca2+ when the NK1R-F was transfected into monocytes. However, the NK1R-T was functional in monocytes, as SP enhanced the CCR5 ligand CCL5-elicited Ca2+ mobilization, a response inhibited by the NK1R antagonist aprepitant. SP interactions with the NK1R-T also enhanced CCL5-mediated chemotaxis, which was ERK1/2-dependent. NK1R-T selectively activated ERK2 but increased ERK1 and ERK2 activation by CCL5. Activation of NK1R-T elicited serine phosphorylation of CCR5, indicating that crosstalk between CCL5 and SP may occur at the level of the receptor. Thus, NK1R-T is functional in human monocytes and activates select signaling pathways, and the NK1R-T-mediated enhancement of CCL5 responses does not require the NK1R terminal cytoplasmic domain.

Key Words: chemokines • MAPKs • calcium mobilization • receptor phosphorylation




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
J. Meshki, S. D. Douglas, J.-P. Lai, L. Schwartz, L. E. Kilpatrick, and F. Tuluc
Neurokinin 1 Receptor Mediates Membrane Blebbing in HEK293 Cells through a Rho/Rho-associated Coiled-coil Kinase-dependent Mechanism
J. Biol. Chem., April 3, 2009; 284(14): 9280 - 9289.
[Abstract] [Full Text] [PDF]